Flag of CN

Über das Unternehmen

Firmenname (rechtlich): Hiray Pharma Solutions Ltd.

Internationaler Name: Hiray Pharma Solutions Ltd., China

Marke / Handelsname: Hiray Pharma Solutions

Registrierungsland: China

Adresse: HubeiJingmenNo. 1, Xinghua 3rd Road, Daodao District, Jingmen City, Hubei Province • Hubei

Beschreibung:

Hiray Pharma Solutions (Hanrui Pharmaceutical, Jingmen), established January 2019 as a wholly-owned subsidiary of Wuhan Haite Biopharmaceutical, operates from a 90,500-square-meter industrial recycling park site in Jingmen City, Hubei, built around seven planned workshops and an API production line with reactors ranging from 30L to 10,000L across 105 units. The company has obtained manufacturing qualifications for APIs including Urapidil Hydrochloride and peramivir, and has established business relationships with five of the world's top ten innovative pharmaceutical companies, working toward its stated vision of becoming a world-class API CDMO enterprise with quality systems aligned to FDA, EMA, and NMPA requirements. It offers CRO and CMO services, custom formulation, and consultation, manufacturing under OEM, ODM, and its own brand, and ships to North America, Asia, Western and Eastern Europe, and Central/South America.

Hiray Pharma Solutions Ltd.

Über das Unternehmen

Geschäftsaktivitäten

Vertrags- & Outsourcing-Dienstleistungen

Laborchemikalien, Lösungsmittel & Referenzstandards

Pharmazeutische Chemikalien

Pharmazeutische Wirkstoffe (API)

Produktionsanlagen & Betriebstechnik

Unsere Produkte & Dienstleistungen

1,2,4-Oxadiazol-5(2H)-one,3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-teChemicalbooktrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahyd

(S)-1-(4-fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1,3-dihydro-2H-imidazol-2-one hydrochloride 2212022-57-4

(S)-1-(4-Fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1H-imidazol-2(3H)-one 2212022-56-3

5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)- 2212022-55-2

1-(4-Methoxyphenyl)-2-benzylaminopropane

1,2,4-Oxadiazol-5(2H)-one, 3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dime

1H-Indole-2-carboxamide, 1-[(1S,2S)-1-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)-2-methylcyclopropyl]-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]- 2212021-82-2

[(1s,2s,4s)-4-amino-3-Hydroxy-5-phenyl-1-phenylmethyl]pentyl-1,1-dimethylethyl ester)

2-Bromo-4'-Benzyloxy-3'-nitroacetophenone

2-CHLOROETHYL METHYL SULFIDE

decahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan-2(1H)-one

(2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate 2212021-56-0

4-Fluoro-3,5-dimethylphenyl)hydrazine hydrochloride 2212021-40-2

5-bromo -4-fluoro -1-methyl -1H-indazole/5-Bromo-4-fluoro-1-methyl-1H-indazole

5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Acid 2212021-83-3

5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 3-amino-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)- 2212021-59-3

5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 3-(2,3-dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl e 2212021-61-7

Compound T11408/2212020-52-3

ORFORGLIP1H-Indole-2-carboxamide, 1-[(1S,2S)-1-cyano-2-methylcyclopropyl]-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-RON intermediate/ 2212021-81-1

ORFORGLIPRON N-7 3047293-01-3

ORFORGLIPRON N-8 3047292-99-6

(S)-3-Aminobutanenitrile hydrochloride 1073666-54-2

(S)-3-Aminobutanenitrile hydrochloride

(S)-5-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-N-methyl-N-phenyl-1H-indole-2-carboxamide 2212021-79-7

Santillactone (racemate)/decahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan-2(1H)-one 1216-84-8

Urolith A 1143-70-0

Certifications

GMP multifunctional and 4 GMP commercial workshops for APIs

GMP workshops for intermediates

GMP multifunctional workshops

GMP commercial workshops and 6 Non-GMP workshops

Bewertungen

Bewertung & Kommentar hinterlassen

Kommentare